UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549
                                  _____________

                                    Form 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     Date of Report (Date of earliest event reportedly): November 13, 2008

                              OCEAN BIO-CHEM, INC.
               (Exact name of registrant as specified in charter)

      Florida                            2-11102                    59-1564329
(State or Other Jurisdiction     (Commission File Number)      (I.R.S. Employer
of Incorporation)                                            Identification No.)

               4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
                (Address of principal executive office Zip Code)

                                 (954) 587-6280
               Registrants telephone number, including area code:

                                 Not Applicable
          (Former name or former address, if changes since last report)

     Check the  appropriate  box below if the Form 8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

     [ ] Written  communications  pursuant to Rule 425 under the  Securities Act
(17 CFR 230.425)

     [ ] Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

     [ ]  Pre-commencement  communications  pursuant to Rule 14d-2(b)  under the
Exchange Act (17 CFR 240.14d-2(b))

     [ ]  Pre-commencement  communications  pursuant to Rule 13e-4(c)  under the
Exchange Act (17 CFR 240.13e-4(c))




     Item 8.01 Other Events

     On November 12, 2008 issued a press  release  announcing a stock buyback of
349,773  shares of common stock at $0.80 per share  common from a  institutional
investor under the Company's previously announced stock buyback program.



Section  9 - Financial Statements and Exhibits

Exhibit 99.1 - Press Release dated November 13, 2008


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

November 13, 2008
                                   Ocean Bio-Chem, Inc.

                                   /s/ Jeffrey S. Barocas
                                   Jeffrey S. Barocas
                                   Chief Financial Officer


                                                                    Exhibit 99.1
                 Ocean Bio Chem., Inc. Announces Stock Buy Back


     Ft.  Lauderdale Fl. November 12, 2008 - Ocean Bio Chem., Inc (Nasdaq OBCI),
announced  that it has reached an  agreement to purchase  349,773  shares of its
common stock at $0.80 per common share from an institutional shareholder,  under
the Company's  previously  authorized stock buyback program. The transaction was
completed on November 11, 2008.

     Ocean Bio Chem- President and CEO stated "We believe this stock buy back is
a financially sound  transaction for both the Company and our shareholders.  The
Board of Directors  and senior  management  believe that the current share price
has presented an opportunity to buy the shares back at an attractive  price.  It
is the  Company's  intent to purchase  stock from time to time as  opportunities
arise."



     Mr. Dornau  continued "The  reduction of 349,773 common shares  outstanding
would have increased net earnings diluted per share - by approximately $0.01 per
share  during the latest 3rd quarter  2008  financial  results.  We believe this
transaction demonstrates the confidence we have in the Company's future"


     About Ocean Bio-Chem

     Ocean Bio-Chem,  Inc.  manufactures  and markets a full line of maintenance
and care products for boats, recreational vehicles, automobiles, motorcycles and
aircraft.  Products  are sold under the  Starbrite"  name.  The  Company  trades
publicly under NASDAQ SmallCap Symbol: OBCI.

     Websiteswww.starbrite.com, www.startron.com, www.oceanbiochem.com

For additional information contact:
Peter Dornau  (954) 587-6280            or:        Jeff Barocas (954) 587-6280
President and CEO, Ocean Bio-Chem, Inc             Chief Financial Officer Ocean
                                                    Bio-Chem, Inc.


     This press release (and oral statements made regarding the subjects of this
release) contains  forward-looking  statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These  forward-looking  statements may
include,  but are not limited to  statements  regarding  Ocean Bio Chem.' plans,
objectives,  expectations and intentions and other statements  contained in this
press release that are not historical facts,  including statements identified by
words  such  as  "expects,"   "should,"   "anticipates,"   "intends,"   "plans,"
"believes,"  "seeks,"  "estimates,"  "will" or words of similar  meaning.  These
forward-looking  statements  are based  upon  management's  current  beliefs  or
expectations and are inherently  subject to significant  business,  economic and
competitive  uncertainties  and  contingencies,  many of which  are  beyond  our
control.  The foregoing  factors,  among others,  could cause actual  results to
differ materially from those described in the forward-looking statements.  Ocean
Bio Chem.  may not realize  benefits from this stock buy back. The statements in
this  press  release  are made as of the  date of this  press  release,  even if
subsequently  made  available  by Ocean Bio Chem.  on its website or  otherwise.
Ocean Bio Chem. does not undertake any obligation to update any  forward-looking
statement  to reflect  circumstances  or events  that occur  after the date such
forward-looking  statement  is made.  For a list of other  factors,  which could
affect  Ocean  Bio  Chem.'  results,  see  Ocean  Bio  Chem.'  filings  with the
Securities and Exchange Commission, including "Item 1A. Risk Factors," set forth
in Ocean Bio Chem.' Annual  Report on Form 10-K for the year ended  December 31,
2008.